(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SOLVD HEALTH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SOLVD HEALTH

ST13

US500000090018315

Class

5, 10, 44

Filing

90018315

Registration

7170077

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

09/04/2025

Classification

Registered

Trademark type

Word

Nice classes

5, 10, 44

Filing date

06/24/2020

Registration date

09/19/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/19/2023

Last transaction

09/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/25/2020

First use in commerce

11/25/2020

Drawing code

4

Owner type

03

Owner location

CARLSBAD, CA

Examiner

NADELMAN, ANDREA

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AUTOGENOMICS, INC.
Prescient Medicine Holdings, Inc.

Representatives

William S. Fultz WOMBLE BOND DICKINSON (US) LLP

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical testing kits comprised of medical diagnostic reagents and assays for detecting genetic predispositions to addiction or substance use disorder for health and medical risk assessment purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancer

Class 10

Apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids; Medical test kits for detecting cancer and precancerous cells composed of medical specimen collection tools and devices for the collection of biological specimensone or more of lancetsswabs for collecting body fluidstest tubessanitizing wipescollection envelopesinstruction manuals; Medical testing apparatus and instruments for detecting genetic predispositions for health and medical risk assessment purposes; Medical testing kits for use in predicting an individual's risk of addiction or substance use disorder composed of medical devicesmachinesapparatusdiagnostic apparatusinstrumentsspecimen collection tools for the collection of DNAone or more of handheld devices containing swabs for obtaining buccal cellslancetsswabssaliva collection tubestest tubeswipescollection envelopesinstruction manuals; Medical testing kits containing biological specimen collection devices in the nature of handheld devices containing swabs for obtaining buccal cellslancetsswabssaliva collection tubestest tubeswipescollection envelopes for the collection of cell tissue containing nucleic acids for use in testing a patient's risk of addiction or substance use disorder

Class 44

Medical diagnostic testingmonitoringreporting services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening; Genetic testing for medical purposes; Drug use testing services; Providing medical testing and reporting services pertaining to a patient's risk of addiction or substance use disorder for diagnostic or treatment purposes; Providing cancer screening services; Medical analysis services for the detection of cancer and precancerous cells for diagnostic or treatment purposes

Publications

History of USPTO decisions and trademark events.

39 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/03/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/19/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/19/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/15/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/14/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/07/2023

IUAF

USE AMENDMENT FILED

08/04/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/04/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/17/2023

EX4G

SOU EXTENSION 4 GRANTED

02/16/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/16/2023

EXT4

SOU EXTENSION 4 FILED

02/01/2023

EEXT

SOU TEAS EXTENSION RECEIVED

02/01/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/13/2022

EX3G

SOU EXTENSION 3 GRANTED

07/11/2022

EXT3

SOU EXTENSION 3 FILED

07/11/2022

EEXT

SOU TEAS EXTENSION RECEIVED

07/11/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/09/2022

EX2G

SOU EXTENSION 2 GRANTED

02/07/2022

EXT2

SOU EXTENSION 2 FILED

02/07/2022

EEXT

SOU TEAS EXTENSION RECEIVED

02/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/03/2021

EX1G

SOU EXTENSION 1 GRANTED

07/30/2021

EXT1

SOU EXTENSION 1 FILED

07/30/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/30/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/09/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/15/2020

PUBO

PUBLISHED FOR OPPOSITION

12/15/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/12/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/21/2020

GNRT

NON-FINAL ACTION E-MAILED

08/21/2020

CNRT

NON-FINAL ACTION WRITTEN

08/21/2020

DOCK

ASSIGNED TO EXAMINER

08/18/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/21/2020

NWAP

NEW APPLICATION ENTERED

06/27/2020

Continuous trademark protection

Get notified about every new filing that threatens SOLVD HEALTH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.